Micro-ribonucleic Acid 494 Regulation of Protein S Expression
Overview
Authors
Affiliations
Background: Acquired protein S (PS) deficiency is highly associated with elevated circulating estrogen levels resulting from pregnancy, oral contraceptives, and estrogen replacement therapy; however, the mechanism of estrogen-mediated acquired PS deficiency remains poorly understood. Increasing evidence indicates that estrogen receptor signaling can indirectly modulate the expression of target genes at the post-transcriptional level by modulating the expression of microRNAs (miRNAs), and miRNAs have also been demonstrated to be involved in the regulation of hemostasis.
Objectives: To investigate the mechanism of estrogen-mediated downregulation of PROS1 expression by the microRNA miR-494.
Methods: Computational analyses of the PROS1 3'-untranslated region (UTR) were performed to identify putative miRNA-binding sites, and direct targeting of the PROS1 3'-UTR by miR-494 was determined with dual luciferase reporter assays in HuH-7 cells. Reporter vectors containing the PROS1 3'-UTR sequence with deleted miR-494-binding sites were also analyzed with luciferase reporter assays. The effects of estrogen on miR-494 and PROS1 mRNA levels in HuH-7 cells were determined by quantitative real-time PCR, and estrogen-mediated changes to secreted PS levels in culture supernatant of HuH-7 cells were measured with an ELISA.
Results: The PROS1 3'-UTR sequence contains three putative miR-494-binding sites. miR-494 directly targets PROS1, and miR-494 levels are upregulated following estrogen treatment in HuH-7 liver cells in association with downregulated PROS1 mRNA and PS levels.
Conclusions: The results from this study provide the first evidence for miRNA downregulation of PROS1 by miR-494, and suggest that miR-494 is involved in the mechanism of estrogen-mediated downregulation of PS expression.
SARS-CoV-2 Vaccine Improved Hemostasis of a Patient with Protein S Deficiency: A Case Report.
Mohammad M, Malik A, Thangada L, Polania-Villanueva D, Zabaleta J, Majumder R Int J Mol Sci. 2024; 25(19).
PMID: 39409046 PMC: 11477061. DOI: 10.3390/ijms251910717.
The Role of TAM Receptors in Bone.
Engelmann J, Ragipoglu D, Ben-Batalla I, Loges S Int J Mol Sci. 2024; 25(1).
PMID: 38203403 PMC: 10779100. DOI: 10.3390/ijms25010233.
Danckwardt S, Tregouet D, Castoldi E Cardiovasc Res. 2023; 119(8):1624-1640.
PMID: 36943786 PMC: 10325701. DOI: 10.1093/cvr/cvad046.
Albumin, oral contraceptives, and venous thromboembolism risk in astronauts.
Zwart S, Aunon-Chancellor S, Heer M, Mark Melin M, Smith S J Appl Physiol (1985). 2022; 132(5):1232-1239.
PMID: 35389755 PMC: 9126217. DOI: 10.1152/japplphysiol.00024.2022.
The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook.
Luo M, Du M, Shu C, Liu S, Li J, Zhang L Front Pharmacol. 2021; 12:743945.
PMID: 34737702 PMC: 8560694. DOI: 10.3389/fphar.2021.743945.